| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/05/2008 | US7408048 Nucleic acid encoding gene-expression modulating agents including sense and antisense molecules, ribozymes and RNAi-type molecules |
| 08/05/2008 | US7408044 Carrier protein having an adjuvant effect |
| 08/05/2008 | US7408043 Neutralizing antibody against HGF |
| 08/05/2008 | US7408042 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 08/05/2008 | US7408040 Antibodies to PDGF-D |
| 08/05/2008 | US7408038 Transmembrane proteins that increases the maturation and/or proliferation of B cells. |
| 08/05/2008 | US7408037 Polypeptide that, when mixed with a peripheral blood-mononuclear cell culture and incubated, induces cytotoxic T lymphocytes that contain HLA-A2-restricted cytotoxic T lymphocytes; anti-cancer vaccine |
| 08/05/2008 | US7408036 Human voltage gated sodium channel β1A subunit and methods of use |
| 08/05/2008 | US7408035 Membrane proteins; antitumor agents; antiproliferative agents; tumor necrosis factor |
| 08/05/2008 | US7408034 PRO20025 polypeptides |
| 08/05/2008 | US7408033 PRO5995 polypeptides |
| 08/05/2008 | US7408032 PRO polypeptides; fused to heterologous polypeptide sequences |
| 08/05/2008 | US7408031 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes |
| 08/05/2008 | US7408029 Tyrosine phosphatase peptides for diagnosis, prevention and treatment of autoimmune diseases; immunotherapy |
| 08/05/2008 | US7408028 Peptides, antibodies thereto, and their use in treatment of central nervous system, damage |
| 08/05/2008 | US7408027 Epitopes of the tau protein which are specifically occurring in a phosphorylated state in tau protein from Alzheimer paired helical filaments; for the generation of antibodies specifically detecting Alzheimer tau protein; for testing drugs effective in dissolving Alzheimer paired helical filaments |
| 08/05/2008 | US7408026 Condensing in presence of catalytic thiol undoxidized sulfhydryl side chain of N-terminal cysteine of one oligopeptide with C-terminal thioester of other to produce intermediate bond, then rearranging to produce amide bond |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407937 Mixture with a cyclic 3', 5'-adenylic acid modulator such as forskolin, activators of adenylate cyclase or macrophages, macrophage-derived factors that stimulate cAMP, calcium ionophores, inhibitors of phosphodiesterase or beta-2-adrenoreceptor or vasoactive intestinal peptide; optional axogenic factor |
| 08/05/2008 | US7407935 Ricin toxin A-chain fragment for use as a vaccine |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407929 Leptin peptide antagonists |
| 08/05/2008 | US7407807 Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles |
| 08/05/2008 | US7407804 Nucleic acid of given sequence with cytosine to thymine substitution; expression vectors; gene therapy for Chronic Obstructive Lung Disease, Adult Respiratory Distress Syndrome, and asthma |
| 08/05/2008 | US7407803 Immunogenic composition comprising bacterial or viral vector, antigen and toxins; escherichia and baculovirus; vaccines |
| 08/05/2008 | US7407791 cell comprising a peptide transport operon mutated such that said cell has increased polypeptide secretion |
| 08/05/2008 | US7407790 Recombinant double-stranded RNA phages and uses thereof |
| 08/05/2008 | US7407789 Polymerizing ability and cellular and humoral immunogenicity decreased as compared with the wild the wild-type staphylokinase; Mutant genes were constructed by PCR site-directed mutagenesis, then recombined with a prokaryotic vector and used to transform E. coli.; thrombolytics and anticoagulant |
| 08/05/2008 | US7407787 Expression vector comprising nucleotide sequences coding polypeptide associated with fructo-oligosaccharide proteins for use in prevention or treatment of infections, diarrheal, cell proliferative and immune system disorders |
| 08/05/2008 | US7407785 Human DNase I hyperactive variants |
| 08/05/2008 | US7407784 L-amino acid oxidase with cytotoxic activity from Aplysia punctata |
| 08/05/2008 | US7407777 IL-2 transmembrane construct |
| 08/05/2008 | US7407776 Engineered zinc finger proteins for regulation of gene expression |
| 08/05/2008 | US7407769 Method of identifying activity modulators of a polycystin-2L1 taste receptor polypeptide |
| 08/05/2008 | US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 |
| 08/05/2008 | US7407765 Human T2R receptors for acetaminophen ranitidine, strychnine and denatomium and related assays for identifying human bitter taste modulators |
| 08/05/2008 | US7407761 Methods for assaying expression of novel galanin receptors |
| 08/05/2008 | US7407756 Using presence of restriction fragment length polymorphisms in inhibitor of kappa light polypeptide gene enhancer (IKAP) and RNA amplification as tool in diagnosing inherited nervous system disorders |
| 08/05/2008 | US7407751 Methods for the detection and prognosis of breast tumors |
| 08/05/2008 | US7407744 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines |
| 08/05/2008 | US7407664 Peptide vaccines against group A streptococci |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407660 Methods and compositions for selective modulation of vascularization |
| 08/05/2008 | US7407657 Of given sequence; derived from Japanese cypress pollen allergen; stimulates lymphocytes; reduce symptoms of pollinosis; immunotherapy and diagnosis |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407655 Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody |
| 08/05/2008 | US7407651 IFN-β liquid formulations |
| 08/05/2008 | US7407475 Modified annexin proteins, and methods and compositions for using them |
| 08/05/2008 | CA2380902C Process to make a sustained release formulation |
| 08/05/2008 | CA2347960C A method of affinity separation and ligands for use therein |
| 08/05/2008 | CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 08/05/2008 | CA2292889C Process for the separation of glycosylated and nonglycosylated proteins |
| 08/05/2008 | CA2290485C Method for the production of non-immunogenic proteins |
| 08/05/2008 | CA2259640C Human glycine transporter |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 08/05/2008 | CA2120514C Synthetic dna sequence having enhanced insecticidal activity in maize |
| 07/31/2008 | WO2008091531A2 Elements for improved expression of bovine somatotropin |
| 07/31/2008 | WO2008091153A1 A functional r-gene from solanum bulbocastanum |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090632A1 Marker for detecting the proposed efficacy of treatment |
| 07/31/2008 | WO2008090263A1 Preli - a novel t-cell regulator |
| 07/31/2008 | WO2008090217A1 Purification of fc-tact fusion proteins using the oilbody technology |
| 07/31/2008 | WO2008090215A1 Factor vii polypeptides with increased affinity to platelets |
| 07/31/2008 | WO2008090211A1 Method for methanol independent induction from methanol inducible promoters in pichia |
| 07/31/2008 | WO2008090174A1 New anti-malaria vaccine compositions and uses thereof |
| 07/31/2008 | WO2008089987A1 Use of gdf-5 for the improvement or maintenance of dermal appearance |
| 07/31/2008 | WO2008089970A1 Sporeformers and screening for sporeformers |
| 07/31/2008 | WO2008089831A2 G-protein coupled receptor 83 as a molecular switch for the induction of regulatory (immunosuppressive) t-cells |
| 07/31/2008 | WO2008089795A1 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 07/31/2008 | WO2008089569A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | WO2008089558A1 Abap1 docking protein |
| 07/31/2008 | WO2008073877A9 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 07/31/2008 | WO2008073161A9 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/31/2008 | WO2008072000A3 Use of integrin alpha 10 binding antibody to modulate extracellular matrix ( cartilage) turnover |
| 07/31/2008 | WO2008067651B1 Gender selection with the use of antibodies |
| 07/31/2008 | WO2008066931A3 Bacillus licheniformis chromosome |
| 07/31/2008 | WO2008065415A3 Protein precipitation using a tag |
| 07/31/2008 | WO2008062010A3 Method for making activated carboxypeptidases |
| 07/31/2008 | WO2008060596A3 Enhanced protein production in t. reesei by co-expression of selected genes |
| 07/31/2008 | WO2008052043A9 Opioid receptor agonist fusion proteins |
| 07/31/2008 | WO2008045955A8 Inhibiting cyclin d polypeptides |
| 07/31/2008 | WO2008041014A3 Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer |
| 07/31/2008 | WO2008031092A9 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 07/31/2008 | WO2008029414A3 Use of transcription factor inhibitor in the manufacture of a medicament |
| 07/31/2008 | WO2008023268A3 Leukemia mouse model conditionally expressing a bcr-abl oncogene |
| 07/31/2008 | WO2008008803A3 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells |
| 07/31/2008 | WO2008004130A3 Peptides for targeting the mitochondrial transition pore complex for therapeutic apoptosis induction and biological applications |
| 07/31/2008 | WO2007149067A3 Methods of using phhla2 to co-stimulate t-cells |
| 07/31/2008 | WO2007107156A3 Chimeric viral envelopes |
| 07/31/2008 | WO2007089899A3 Water-soluble (g protein)-coupled receptor protein |
| 07/31/2008 | WO2007082068A3 Methods and compositions for treating asthma in human and non human primates |
| 07/31/2008 | WO2007059298A3 Chimeric immunoreceptor useful in treating human cancers |
| 07/31/2008 | WO2007022273A3 Vegf-activated fas ligands |
| 07/31/2008 | WO2007008697A3 Compositions and methods for refolding of denatured proteins |
| 07/31/2008 | WO2001044293A8 Sodium channel proteins |
| 07/31/2008 | US20080184397 Acquired Resistance Genes in Plants |
| 07/31/2008 | US20080184392 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens |